5-Year OS Nears 40% in BRAF Wild Kind Melanoma

5-Year OS Nears 40% in BRAF Wild Kind Melanoma

Uncategorized

(MedPage At this time) — Almost 40% of sufferers with stepped forward BRAF wild form melanoma remained alive at 5 years after treatment with the PD-1 inhibitor nivolumab (Opdivo), observe-up files from a randomized trial confirmed.
By comparison, fewer than half…
Read Extra

Leave a Reply

Your email address will not be published. Required fields are marked *